What is the treatment for tinea glutealis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Tinea Glutealis

The first-line treatment for tinea glutealis (ringworm of the buttocks) is topical antifungal medication applied once daily for 1-2 weeks, with oral antifungal therapy reserved for extensive disease, immunocompromised patients, or cases that fail topical treatment. 1

Diagnosis

Before initiating treatment, confirm the diagnosis through:

  • Clinical examination of the affected area
  • Mycological confirmation by obtaining specimens using scalpel scraping, plucking, or brushing techniques
  • Sending specimens for microscopy and culture to identify the causative organism 1

Treatment Algorithm

First-Line Treatment:

  1. Topical antifungal medications:
    • Azoles (clotrimazole 1%, miconazole, econazole)
    • Allylamines (terbinafine 1%, naftifine 1%)
    • Apply once daily for 1-2 weeks 1, 2

For Extensive Disease or Treatment Failures:

  1. Oral antifungal therapy options:
    • Terbinafine: 250 mg daily for adults for 2 weeks 1
    • Itraconazole: 100 mg daily for 2 weeks or 200 mg daily for 1 week 1
    • Fluconazole: 150 mg once weekly for 2-4 weeks 3, 4

Treatment Duration:

  • Continue treatment for at least one week after clinical clearing of infection 5
  • The endpoint should be mycological cure, not just clinical improvement 1

Special Considerations

For Inflammatory Lesions:

  • Consider using an agent with inherent anti-inflammatory properties
  • Combination antifungal/steroid agents may be used short-term, but with caution due to potential for skin atrophy 5

For Treatment Failures:

  1. Consider:

    • Lack of compliance
    • Suboptimal absorption of medication
    • Relative insensitivity of the organism
    • Reinfection
    • Alternative diagnosis 6
  2. If there is clinical improvement but ongoing positive mycology:

    • Continue current therapy for an additional 2-4 weeks 6
  3. If no initial clinical improvement:

    • Switch antifungal class (e.g., from azole to terbinafine or vice versa) 1

Prevention of Recurrence

  • Keep affected areas clean and dry
  • Wear loose-fitting cotton underwear
  • Change underwear daily or more frequently if sweating
  • Use separate towels for drying the affected area
  • Apply antifungal powders to susceptible areas to prevent reinfection 1

Evidence Quality and Considerations

The evidence for topical treatments shows that most antifungal agents are effective for tinea infections, with clinical cure rates significantly higher than placebo 2. Topical terbinafine and naftifine have demonstrated particularly strong evidence of efficacy 2.

For oral therapy, studies show that fluconazole (150 mg weekly) achieved 95% cure rates for tinea corporis/cruris 3, while terbinafine and itraconazole also demonstrate high efficacy rates 7.

It's worth noting that while combination antifungal/steroid medications may provide faster symptomatic relief, they should be used cautiously and for short durations due to potential steroid-related side effects 5.

References

Guideline

Management of Recurrent Tinea Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Research

Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Research

Fluconazole in the treatment of tinea corporis and tinea cruris.

Dermatology (Basel, Switzerland), 1998

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.